ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
147 hedge funds and large institutions have $386M invested in Intercept Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 49 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
6% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 49
Holders
147
Holding in Top 10
–
Calls
$21M
Puts
$14.6M
Top Buyers
| 1 | +$7.69M | |
| 2 | +$6.88M | |
| 3 | +$6.79M | |
| 4 |
Morgan Stanley
New York
|
+$6.06M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$5.15M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$7.12M | |
| 3 | -$2.98M | |
| 4 |
Citigroup
New York
|
-$2.98M |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
-$2.75M |